Astria Therapeutics

Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.

HQ location

Boston, United States

Website

Launch date

Jul 2008

Employees

Market cap

Enterprise value

$208m

Share price

$6.53 ATXS

Recent deals

Quellis Biosciences

https://twitter.com/astriatx https://www.facebook.com/astriatx https://www.linkedin.com/company/catabasis-pharmaceuticals-inc-

Authorizing premium user...